Lindi Jiang

2.1k total citations
78 papers, 893 citations indexed

About

Lindi Jiang is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Immunology. According to data from OpenAlex, Lindi Jiang has authored 78 papers receiving a total of 893 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pulmonary and Respiratory Medicine, 31 papers in Rheumatology and 22 papers in Immunology. Recurrent topics in Lindi Jiang's work include Vasculitis and related conditions (41 papers), Atherosclerosis and Cardiovascular Diseases (16 papers) and Renal Diseases and Glomerulopathies (13 papers). Lindi Jiang is often cited by papers focused on Vasculitis and related conditions (41 papers), Atherosclerosis and Cardiovascular Diseases (16 papers) and Renal Diseases and Glomerulopathies (13 papers). Lindi Jiang collaborates with scholars based in China, Austria and United States. Lindi Jiang's co-authors include Lili Ma, Xiaomin Dai, Huiyong Chen, Ying Sun, Xiufang Kong, Xiaomeng Cui, Xuejuan Jin, Rongyi Chen, Yun Liu and Fuhua Yan and has published in prestigious journals such as Nature Communications, PLoS ONE and Chemical Engineering Journal.

In The Last Decade

Lindi Jiang

70 papers receiving 887 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lindi Jiang China 17 332 318 245 245 144 78 893
Abraham Rutgers Netherlands 23 940 2.8× 595 1.9× 222 0.9× 527 2.2× 305 2.1× 89 1.7k
M Nakano Japan 14 129 0.4× 255 0.8× 125 0.5× 135 0.6× 128 0.9× 49 649
H. Devilliers France 17 405 1.2× 637 2.0× 59 0.2× 209 0.9× 113 0.8× 69 990
Charles E. Alpers United States 14 114 0.3× 190 0.6× 307 1.3× 161 0.7× 236 1.6× 17 812
Branka Bonači‐Nikolić Serbia 14 218 0.7× 227 0.7× 60 0.2× 195 0.8× 127 0.9× 49 691
Andrew D. Frutkin United States 14 221 0.7× 111 0.3× 213 0.9× 148 0.6× 307 2.1× 18 1.2k
Yukihiro Wada Japan 17 155 0.5× 67 0.2× 327 1.3× 198 0.8× 203 1.4× 50 787
Mikako Warren United States 12 136 0.4× 83 0.3× 88 0.4× 201 0.8× 112 0.8× 47 668
Kimihiro Suzuki Japan 16 212 0.6× 291 0.9× 43 0.2× 244 1.0× 103 0.7× 59 869
Bonnie Mitchell United States 14 81 0.2× 213 0.7× 130 0.5× 223 0.9× 155 1.1× 28 804

Countries citing papers authored by Lindi Jiang

Since Specialization
Citations

This map shows the geographic impact of Lindi Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lindi Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lindi Jiang more than expected).

Fields of papers citing papers by Lindi Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lindi Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lindi Jiang. The network helps show where Lindi Jiang may publish in the future.

Co-authorship network of co-authors of Lindi Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Lindi Jiang. A scholar is included among the top collaborators of Lindi Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lindi Jiang. Lindi Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jun, Zhang, X. W. Xu, Boyu Liu, et al.. (2025). Modulating Mn3+/Mn4+ Redox Couples in Pd/OMS-2 through Pd–O–Mn Interfacial Chemical Bonds for Boosting Electrocatalytic Oxygen Reduction and Methanol Oxidation. ACS Sustainable Chemistry & Engineering. 13(18). 6507–6517. 2 indexed citations
2.
Sun, Ying, et al.. (2024). Pro-fibrotic effect of the susceptible gene PCSK5 in vascular fibrosis of Takayasu arteritis via TGF-β and SMAD3 signaling pathway activation. Journal of Autoimmunity. 148. 103277–103277. 3 indexed citations
3.
Sun, Ying, et al.. (2024). Epidemiology of large vasculitis in Shanghai, China: A 10‐year multicenter hospital‐based study and systematic review. International Journal of Rheumatic Diseases. 27(10). e15360–e15360. 1 indexed citations
4.
Jun, Zhang, X. W. Xu, Boyu Liu, et al.. (2024). High/Low-Index Faceted PdNi Alloy Nanocrystals as Highly Active and Stable Electrocatalyst for Oxygen Reduction. Chemical Engineering Journal. 503. 158187–158187. 7 indexed citations
5.
Ji, Zongfei, Ying Sun, Lijuan Zhang, Xiufang Kong, & Lindi Jiang. (2024). Predictors of irreversible renal dysfunction in patients with idiopathic retroperitoneal fibrosis. Lara D. Veeken. 64(5). 2855–2861.
6.
Kong, Xiufang, et al.. (2023). COVID-19 vaccine uptake, hesitancy and clinical effects on patients with Takayasu’s arteritis: A web-based questionnaire survey from a large cohort. Frontiers in Immunology. 14. 1030810–1030810. 1 indexed citations
7.
Jin, Jiayu, Jieyu Guo, Qi Pan, et al.. (2023). BACH1 controls hepatic insulin signaling and glucose homeostasis in mice. Nature Communications. 14(1). 8428–8428. 24 indexed citations
8.
Chen, Rongyi, Lingying Ma, Xiaomin Dai, et al.. (2023). High level of serum complement 3 is a risk factor for vascular stenosis progression in TA patients receiving tocilizumab: a prospective observational study. Arthritis Research & Therapy. 25(1). 137–137. 2 indexed citations
9.
Liu, Yun, Yifan Feng, Xiufang Kong, et al.. (2023). A microRNA sponge, LINC02193, promotes neutrophil activation by upregulating ICAM1 and is correlated with ANCA-associated vasculitis. Lara D. Veeken. 63(8). 2295–2306. 2 indexed citations
10.
Mao, Kaimin, et al.. (2023). Identification of key candidate genes and pathways in rheumatoid arthritis and osteoarthritis by integrated bioinformatical analysis. Frontiers in Genetics. 14. 1083615–1083615. 4 indexed citations
11.
Guo, Jieyu, Yueyang Yu, Jiayu Jin, et al.. (2023). BACH1 regulates the differentiation of vascular smooth muscle cells from human embryonic stem cells via CARM1-mediated methylation of H3R17. Cell Reports. 42(12). 113468–113468. 3 indexed citations
12.
Liu, Dongmei, Zhen Li, Zongfei Ji, et al.. (2022). Effectiveness of benzbromarone versus febuxostat in gouty patients: a retrospective study. Clinical Rheumatology. 41(7). 2121–2128. 10 indexed citations
14.
Kong, Xiufang, Sifan Wu, Ying Sun, et al.. (2022). A comprehensive profile of chemokines in the peripheral blood and vascular tissue of patients with Takayasu arteritis. Arthritis Research & Therapy. 24(1). 49–49. 10 indexed citations
15.
Li, Yanshan, Xiaomeng Cui, Qian Jia, et al.. (2019). High melatonin levels are related to spinal ossification in patients with ankylosing spondylitis. Modern Rheumatology. 30(2). 373–378. 3 indexed citations
16.
Zhang, Fengchun, Zhichun Liu, Lindi Jiang, et al.. (2019). A Randomized, Double-Blind, Non-Inferiority Study of Febuxostat Versus Allopurinol in Hyperuricemic Chinese Subjects With or Without Gout. Rheumatology and Therapy. 6(4). 543–557. 9 indexed citations
17.
Chen, Xiaoxiang, Zhanguo Li, Huaxiang Wu, et al.. (2016). A randomized, controlled trial of efficacy and safety of Anbainuo, a bio-similar etanercept, for moderate to severe rheumatoid arthritis inadequately responding to methotrexate. Clinical Rheumatology. 35(9). 2175–2183. 8 indexed citations
19.
Liu, Yi, Patrick Danoy, Xinyu Wu, et al.. (2010). Association of STAT3 and TNFRSF1A with ankylosing spondylitis in Han Chinese. Annals of the Rheumatic Diseases. 70(2). 289–292. 98 indexed citations
20.
Jiang, Lindi. (2009). A Comparison between Methods of Assessing Utility Values in Rheumatoid Arthritis. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026